| 000 | 01814 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517040001.0 | ||
| 264 | 0 | _c20160809 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1097-4644 | ||
| 024 | 7 |
_a10.1002/jcb.25241 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchoeman, Monique A E | |
| 245 | 0 | 0 |
_aInhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation. _h[electronic resource] |
| 260 |
_bJournal of cellular biochemistry _cDec 2015 |
||
| 300 |
_a2938-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Morphogenetic Protein 4 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBone Morphogenetic Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGenetic Markers |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGlycogen Synthase Kinase 3 beta |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aOsteoblasts _xmetabolism |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 |
_aWnt Signaling Pathway _xdrug effects |
| 650 | 0 | 4 |
_aWnt3A Protein _xadministration & dosage |
| 650 | 0 | 4 |
_abeta Catenin _xmetabolism |
| 700 | 1 | _aMoester, Martiene J C | |
| 700 | 1 | _aOostlander, Angela E | |
| 700 | 1 | _aKaijzel, Eric L | |
| 700 | 1 | _aValstar, Edward R | |
| 700 | 1 | _aNelissen, Rob G H H | |
| 700 | 1 | _aLöwik, Clemens W G M | |
| 700 | 1 | _ade Rooij, Karien E | |
| 773 | 0 |
_tJournal of cellular biochemistry _gvol. 116 _gno. 12 _gp. 2938-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcb.25241 _zAvailable from publisher's website |
| 999 |
_c25002246 _d25002246 |
||